X

Se advierte al usuario del uso de cookies propias y de terceros de personalización y de análisis al navegar por esta página web para mejorar nuestros servicios y recopilar información estrictamente estadística de la navegación en nuestro sitio web. Si continúa navegando, consideramos que acepta su uso. Puede cambiar su configuración u obtener más información.

Corporate

eKuore participates in the Health Partering Event H2020 in Brussels

The CEO of eKuore, Rubén López, will participate next Thursday, September 17th at the Health Partering Event H2020 held in Brussels.

eKuore Pro

eKuore Pro

It is a business meeting with five-minute presentations and bilateral meetings on health and technological developments. Health Partering Event H2020 will offer health sector researchers and companies the opportunity to discuss new project ideas and find potential partners for their funding request Horizon 2020. The event will focus on the next call for proposals in “Health, demographic change and well-being “.

eKuore was chosen by the European Commission to subsidize the launch of its eKuore Pro electronic stethoscope within the Horizon 2020 Program, with an aid of 50,000 euros through the “Pyme Instrument”.

The first wireless medical electronic stethoscope, operable through a market app, eKuore Pro, will be launched on the market in the last quarter of 2015, with a presentation at the main European health fair, MEDICA, in Düsseldorf (Germany).

eKuore is revolutionizing the field of health telecare (mHealth) through this innovative ICT tool, and for that it is already working on identifying strategic partners that allow it to grow in the healthcare market.

About the “Horizon 2020” Program

The European Union concentrates a large part of its research and innovation activities in the Horizon 2020 Framework Program. In the period 2014-2020 and through the implementation of three pillars, it contributes to addressing the main social challenges, promoting industrial leadership in Europe and strengthening the excellence of its scientific base. The available budget will amount to € 76,880 million.